Larimar Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LRMR and other ETFs, options, and stocks.

About LRMR

Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. 

CEO
Carole S. Ben-Maimon
CEOCarole S. Ben-Maimon
Employees
42
Employees42
Headquarters
Bala Cynwyd, Pennsylvania
HeadquartersBala Cynwyd, Pennsylvania
Founded
2005
Founded2005
Employees
42
Employees42

LRMR Key Statistics

Market cap
403.85M
Market cap403.85M
Price-Earnings ratio
-7.52
Price-Earnings ratio-7.52
Dividend yield
—
Dividend yield—
Average volume
324.31K
Average volume324.31K
High today
$6.38
High today$6.38
Low today
$5.91
Low today$5.91
Open price
$6.29
Open price$6.29
Volume
302.13K
Volume302.13K
52 Week high
$13.68
52 Week high$13.68
52 Week low
$2.18
52 Week low$2.18

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.